Dr. Abou-Alfa is Attending Physician and Professor at Memorial Sloan Kettering Cancer Center (New York, NY), and a global leader in clinical research on liver and biliary cancers. He pioneered the use of targeted drugs and immunotherapies for these diseases, contributing to regulatory approvals and the establishment of new standards of care. Dr. Abou-Alfa led the first multi-center clinical trials on FLC, establishing that such studies are feasible in this rare disease.